Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma

Ann Hematol. 2019 Aug;98(8):2017-2018. doi: 10.1007/s00277-019-03664-4. Epub 2019 Mar 16.

Authors

Andrea Marra¹, Giovanni Martino², Stefano Ascani³, Maria Paola Martelli², Brunangelo Falini²

Affiliations

¹ Institute of Haematology and Centre of Haemato-Oncology Research (CREO), University and Hospital of Perugia, Perugia, Italy. andrea.marra1987@gmail.com.
² Institute of Haematology and Centre of Haemato-Oncology Research (CREO), University and Hospital of Perugia, Perugia, Italy.
³ Department of Experimental Medicine-Section of Pathologic Anatomy and Histology Medical School, University of Perugia, Perugia, Italy.

PMID: 30879096
DOI: 10.1007/s00277-019-03664-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Allografts
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow Transplantation
Bone Neoplasms / diagnosis*
Bone Neoplasms / genetics
Bone Neoplasms / pathology
Bone Neoplasms / therapy
Combined Modality Therapy
Diagnosis, Differential
Fatal Outcome
Female
Humans
Leukemia, Myeloid, Acute / diagnosis
Neoplasm Proteins / genetics*
Nuclear Proteins / genetics*
Nucleophosmin
Salvage Therapy
Sarcoma, Ewing / diagnosis*
Sarcoma, Myeloid / diagnosis*
Sarcoma, Myeloid / genetics
Sarcoma, Myeloid / pathology
Sarcoma, Myeloid / therapy
Young Adult

Substances

NPM1 protein, human
Neoplasm Proteins
Nuclear Proteins
Nucleophosmin